Skip to main content
ENGN logo

ENGN · enGene Therapeutics Inc. · Holdings

Track ENGN — free
$1.81 -0.07 (-3.48%)
Market Cap
$125.32M
Shares
67.02M
Volume · Oct 6 221.15K Avg daily vol (3M) 808.13K

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Some SEC filings for this period have not finished importing. Holder totals and changes may be incomplete; these filings remain queued for recovery.
Holders: 70
Total Value: $87,390,437
Total Shares: 53,045,049

Institutional Ownership Trend

11 quarters

Holder Concentration

Across 70 13F filers · Δ vs Mar 31, 2026
Top Holder
19.1%
Dec 2023 → Jun 2026 · range 16.4% – 61.2%
+1.9 pts
Top 5
59.5%
Dec 2023 → Jun 2026 · range 48.7% – 98.5%
+6.3 pts
Top 10
76.3%
Dec 2023 → Jun 2026 · range 72.3% – 100.0%
−0.3 pts
HHI
898
Dec 2023 → Jun 2026 · range 700 – 4,156
Broadly held+122

Quarterly Activity

vs Mar 31, 2026
New
30
Increased
15
Decreased
17
Sold Out
22
Unchanged
8
Holder count: +8
Institutional value: -77.2%
Shares held: -5.7%

Top Buyers

vs Mar 31, 2026
Institution Added Now Holds Open

Top Sellers

vs Mar 31, 2026
Institution Sold Now Holds Open

Top New Positions

vs Mar 31, 2026
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Mar 31, 2026
Institution Previously Held Last Value (USD) Open
Showing 77 of 77
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1980845 CUSIP 29286X101 13F (30d) 1 filings 1 filers Visit website Investor relations